

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.39359030 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.15033457 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.82660432 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.63951129 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.53072126 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.44470668 |
| 7 | glutamate secretion (GO:0014047) | 5.37339583 |
| 8 | vocalization behavior (GO:0071625) | 5.36053619 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.20297812 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.04353802 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.98918724 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.79360143 |
| 13 | regulation of synaptic vesicle transport (GO:1902803) | 4.51492282 |
| 14 | neurotransmitter secretion (GO:0007269) | 4.51373804 |
| 15 | protein localization to synapse (GO:0035418) | 4.46940571 |
| 16 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.39981900 |
| 17 | neuronal action potential propagation (GO:0019227) | 4.30450308 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.27983823 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.24638735 |
| 20 | layer formation in cerebral cortex (GO:0021819) | 4.23062036 |
| 21 | cellular potassium ion homeostasis (GO:0030007) | 4.22220217 |
| 22 | exploration behavior (GO:0035640) | 4.20572765 |
| 23 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.16741372 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 4.14947092 |
| 25 | regulation of synapse structural plasticity (GO:0051823) | 4.13878158 |
| 26 | sodium ion export (GO:0071436) | 4.10595215 |
| 27 | cerebellar granule cell differentiation (GO:0021707) | 4.05594391 |
| 28 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.02826065 |
| 29 | synaptic transmission, glutamatergic (GO:0035249) | 3.94943519 |
| 30 | amino acid import (GO:0043090) | 3.93588581 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.92761735 |
| 32 | cellular sodium ion homeostasis (GO:0006883) | 3.88119662 |
| 33 | long-term memory (GO:0007616) | 3.85333954 |
| 34 | neuron-neuron synaptic transmission (GO:0007270) | 3.82745518 |
| 35 | dendritic spine morphogenesis (GO:0060997) | 3.79223761 |
| 36 | neurotransmitter transport (GO:0006836) | 3.74197542 |
| 37 | proline transport (GO:0015824) | 3.72052580 |
| 38 | positive regulation of membrane potential (GO:0045838) | 3.71186713 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.68726680 |
| 40 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.63171552 |
| 41 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.61857197 |
| 42 | neuromuscular process controlling posture (GO:0050884) | 3.60179211 |
| 43 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.59350102 |
| 44 | gamma-aminobutyric acid transport (GO:0015812) | 3.59275154 |
| 45 | regulation of postsynaptic membrane potential (GO:0060078) | 3.58077809 |
| 46 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.52291608 |
| 47 | activation of protein kinase A activity (GO:0034199) | 3.52142741 |
| 48 | synaptic vesicle endocytosis (GO:0048488) | 3.50082790 |
| 49 | regulation of neurotransmitter levels (GO:0001505) | 3.46381495 |
| 50 | regulation of synaptic plasticity (GO:0048167) | 3.45701568 |
| 51 | regulation of neurotransmitter secretion (GO:0046928) | 3.44902765 |
| 52 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.43409075 |
| 53 | central nervous system myelination (GO:0022010) | 3.40353017 |
| 54 | axon ensheathment in central nervous system (GO:0032291) | 3.40353017 |
| 55 | positive regulation of synapse maturation (GO:0090129) | 3.39666513 |
| 56 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.39070571 |
| 57 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.38102456 |
| 58 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.37801562 |
| 59 | neuron recognition (GO:0008038) | 3.37251443 |
| 60 | membrane hyperpolarization (GO:0060081) | 3.36160341 |
| 61 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.32521128 |
| 62 | long-term synaptic potentiation (GO:0060291) | 3.30364889 |
| 63 | regulation of vesicle fusion (GO:0031338) | 3.29873347 |
| 64 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.29710498 |
| 65 | cell communication by electrical coupling (GO:0010644) | 3.29592648 |
| 66 | transmission of nerve impulse (GO:0019226) | 3.26415452 |
| 67 | serotonin metabolic process (GO:0042428) | 3.22516409 |
| 68 | positive regulation of neurotransmitter transport (GO:0051590) | 3.22053551 |
| 69 | regulation of neurotransmitter transport (GO:0051588) | 3.21750467 |
| 70 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.19548496 |
| 71 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.18879757 |
| 72 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.18710815 |
| 73 | regulation of ARF protein signal transduction (GO:0032012) | 3.16200070 |
| 74 | neuromuscular process controlling balance (GO:0050885) | 3.15914143 |
| 75 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.12977509 |
| 76 | neurotransmitter uptake (GO:0001504) | 3.12920750 |
| 77 | axonal fasciculation (GO:0007413) | 3.11377994 |
| 78 | response to histamine (GO:0034776) | 3.11089227 |
| 79 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.10859312 |
| 80 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.10592638 |
| 81 | L-amino acid import (GO:0043092) | 3.08608841 |
| 82 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.08102839 |
| 83 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.08021432 |
| 84 | behavioral fear response (GO:0001662) | 3.07985367 |
| 85 | behavioral defense response (GO:0002209) | 3.07985367 |
| 86 | innervation (GO:0060384) | 3.06828181 |
| 87 | membrane depolarization (GO:0051899) | 3.03262841 |
| 88 | regulation of synapse maturation (GO:0090128) | 3.03262056 |
| 89 | membrane depolarization during action potential (GO:0086010) | 3.02908812 |
| 90 | intraspecies interaction between organisms (GO:0051703) | 3.02516470 |
| 91 | social behavior (GO:0035176) | 3.02516470 |
| 92 | mating behavior (GO:0007617) | 3.01400375 |
| 93 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.01171280 |
| 94 | dendrite morphogenesis (GO:0048813) | 2.99706916 |
| 95 | glycine transport (GO:0015816) | 2.99213640 |
| 96 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.97547036 |
| 97 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.97169382 |
| 98 | L-phenylalanine catabolic process (GO:0006559) | 2.96985706 |
| 99 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.96985706 |
| 100 | acidic amino acid transport (GO:0015800) | 2.96167824 |
| 101 | prepulse inhibition (GO:0060134) | 2.95888998 |
| 102 | neuronal ion channel clustering (GO:0045161) | 2.95587939 |
| 103 | positive regulation of synaptic transmission (GO:0050806) | 2.94338960 |
| 104 | fear response (GO:0042596) | 2.93704416 |
| 105 | response to auditory stimulus (GO:0010996) | 2.93306968 |
| 106 | regulation of cell communication by electrical coupling (GO:0010649) | 2.93173641 |
| 107 | potassium ion import (GO:0010107) | 2.92994491 |
| 108 | righting reflex (GO:0060013) | 2.91729256 |
| 109 | regulation of synaptic transmission (GO:0050804) | 2.91089672 |
| 110 | learning (GO:0007612) | 2.90722564 |
| 111 | positive regulation of dendritic spine development (GO:0060999) | 2.90092116 |
| 112 | synaptic transmission (GO:0007268) | 2.90055971 |
| 113 | auditory behavior (GO:0031223) | 2.89512002 |
| 114 | potassium ion homeostasis (GO:0055075) | 2.89234144 |
| 115 | startle response (GO:0001964) | 2.88635652 |
| 116 | regulation of dendritic spine development (GO:0060998) | 2.88217184 |
| 117 | cerebellar Purkinje cell layer development (GO:0021680) | 2.87105027 |
| 118 | postsynaptic membrane organization (GO:0001941) | 2.85447510 |
| 119 | primary amino compound metabolic process (GO:1901160) | 2.83299789 |
| 120 | presynaptic membrane organization (GO:0097090) | 2.76964211 |
| 121 | cell communication involved in cardiac conduction (GO:0086065) | 2.73954663 |
| 122 | dendritic spine organization (GO:0097061) | 2.65906451 |
| 123 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.64905882 |
| 124 | L-phenylalanine metabolic process (GO:0006558) | 2.64905882 |
| 125 | dicarboxylic acid transport (GO:0006835) | 2.64263459 |
| 126 | cell differentiation in hindbrain (GO:0021533) | 2.63729227 |
| 127 | negative regulation of dendrite development (GO:2000171) | 2.60901573 |
| 128 | presynaptic membrane assembly (GO:0097105) | 2.59080003 |
| 129 | L-glutamate transport (GO:0015813) | 2.56528967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.63101604 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.11250986 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.00025731 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.93523857 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93310298 |
| 6 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.66051417 |
| 7 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.66051417 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.61757939 |
| 9 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.52589443 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.50589371 |
| 11 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49823184 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48403871 |
| 13 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.47726503 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.45957777 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.43404984 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.36909547 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36443262 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.22317597 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16190705 |
| 20 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.15669113 |
| 21 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15481047 |
| 22 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.10706180 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.02124772 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.95675615 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.91904242 |
| 26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.87367957 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.87108475 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.80307412 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.78290957 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.73724356 |
| 31 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.65741079 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64721999 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63804821 |
| 34 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62178216 |
| 35 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.57351345 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50019335 |
| 37 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46446042 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.46180339 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45337207 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43799680 |
| 41 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37297045 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33659906 |
| 43 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31145324 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29791223 |
| 45 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28814506 |
| 46 | P300_19829295_ChIP-Seq_ESCs_Human | 1.28458390 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.26738625 |
| 48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.26419937 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.25671441 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25558216 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24664719 |
| 52 | * AR_19668381_ChIP-Seq_PC3_Human | 1.24076717 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24076158 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24025546 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23622042 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23511801 |
| 57 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.21677304 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21500056 |
| 59 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21201311 |
| 60 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20219394 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19990467 |
| 62 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19764366 |
| 63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19236324 |
| 64 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17224079 |
| 65 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.15088055 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14646190 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.14506173 |
| 68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14479471 |
| 69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.14018929 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13546180 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13336722 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10465587 |
| 73 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10330760 |
| 74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09902430 |
| 75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09240198 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08967358 |
| 77 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08956067 |
| 78 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08114843 |
| 79 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07120833 |
| 80 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.06409448 |
| 81 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04646728 |
| 82 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03838781 |
| 83 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03601420 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02738703 |
| 85 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02336962 |
| 86 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.01560049 |
| 87 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01555279 |
| 88 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99733044 |
| 89 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99552206 |
| 90 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99283220 |
| 91 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99087944 |
| 92 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98713000 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98583459 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98065031 |
| 95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98028749 |
| 96 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97190504 |
| 97 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96882748 |
| 98 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94893581 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94518349 |
| 100 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93545708 |
| 101 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92797929 |
| 102 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.92667448 |
| 103 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92309650 |
| 104 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92221706 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91600884 |
| 106 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90813424 |
| 107 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89761317 |
| 108 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89322617 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88413811 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88413811 |
| 111 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87437896 |
| 112 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.86404898 |
| 113 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.85738252 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85506152 |
| 115 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83721484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.59400630 |
| 2 | MP0003880_abnormal_central_pattern | 4.72685820 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.13779551 |
| 4 | MP0004270_analgesia | 3.63777790 |
| 5 | MP0009745_abnormal_behavioral_response | 3.31630507 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.26424051 |
| 7 | MP0002064_seizures | 3.14973794 |
| 8 | MP0009046_muscle_twitch | 3.12573658 |
| 9 | MP0005423_abnormal_somatic_nervous | 3.07079425 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.76246447 |
| 11 | MP0002822_catalepsy | 2.67606959 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.66615537 |
| 13 | MP0001486_abnormal_startle_reflex | 2.64727460 |
| 14 | MP0002272_abnormal_nervous_system | 2.56832144 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.55469395 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.55306140 |
| 17 | MP0003011_delayed_dark_adaptation | 2.35104376 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 2.31958176 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.00471115 |
| 20 | MP0001440_abnormal_grooming_behavior | 1.98992521 |
| 21 | MP0002909_abnormal_adrenal_gland | 1.89489182 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.87367607 |
| 23 | MP0006276_abnormal_autonomic_nervous | 1.85042840 |
| 24 | MP0001970_abnormal_pain_threshold | 1.84815638 |
| 25 | MP0008569_lethality_at_weaning | 1.83395589 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.83176875 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.82416922 |
| 28 | MP0002736_abnormal_nociception_after | 1.80110806 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.74378118 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.73361675 |
| 31 | MP0004924_abnormal_behavior | 1.73361675 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.70888950 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.70157882 |
| 34 | MP0003787_abnormal_imprinting | 1.68247115 |
| 35 | MP0002184_abnormal_innervation | 1.66642966 |
| 36 | MP0004811_abnormal_neuron_physiology | 1.65383299 |
| 37 | MP0003879_abnormal_hair_cell | 1.65188793 |
| 38 | MP0003329_amyloid_beta_deposits | 1.64529018 |
| 39 | MP0000778_abnormal_nervous_system | 1.63557234 |
| 40 | MP0001984_abnormal_olfaction | 1.54515855 |
| 41 | MP0003868_abnormal_feces_composition | 1.52894856 |
| 42 | MP0004858_abnormal_nervous_system | 1.52674147 |
| 43 | MP0001502_abnormal_circadian_rhythm | 1.49762221 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.47494476 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.45916171 |
| 46 | MP0004885_abnormal_endolymph | 1.42032228 |
| 47 | MP0000955_abnormal_spinal_cord | 1.38078774 |
| 48 | MP0005085_abnormal_gallbladder_physiolo | 1.37584420 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.36062313 |
| 50 | MP0001905_abnormal_dopamine_level | 1.33549133 |
| 51 | MP0003633_abnormal_nervous_system | 1.33082664 |
| 52 | MP0003122_maternal_imprinting | 1.31911376 |
| 53 | MP0000569_abnormal_digit_pigmentation | 1.27382078 |
| 54 | MP0005365_abnormal_bile_salt | 1.24790377 |
| 55 | MP0001529_abnormal_vocalization | 1.13740924 |
| 56 | MP0002229_neurodegeneration | 1.12653982 |
| 57 | MP0003631_nervous_system_phenotype | 1.12584375 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.12223748 |
| 59 | MP0010386_abnormal_urinary_bladder | 1.10723224 |
| 60 | MP0008875_abnormal_xenobiotic_pharmacok | 1.10637517 |
| 61 | MP0000751_myopathy | 1.08710583 |
| 62 | MP0008872_abnormal_physiological_respon | 1.08614979 |
| 63 | MP0002090_abnormal_vision | 1.07795507 |
| 64 | MP0002152_abnormal_brain_morphology | 1.04862841 |
| 65 | MP0004142_abnormal_muscle_tone | 1.04068162 |
| 66 | MP0004145_abnormal_muscle_electrophysio | 1.04060311 |
| 67 | MP0006072_abnormal_retinal_apoptosis | 1.02611483 |
| 68 | MP0002638_abnormal_pupillary_reflex | 1.01986801 |
| 69 | MP0003123_paternal_imprinting | 1.00878428 |
| 70 | MP0005360_urolithiasis | 1.00451086 |
| 71 | MP0005253_abnormal_eye_physiology | 0.95590421 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.94191766 |
| 73 | MP0004085_abnormal_heartbeat | 0.94037648 |
| 74 | MP0005535_abnormal_body_temperature | 0.93297908 |
| 75 | MP0003075_altered_response_to | 0.92198001 |
| 76 | MP0005187_abnormal_penis_morphology | 0.91453502 |
| 77 | MP0002069_abnormal_eating/drinking_beha | 0.89984844 |
| 78 | MP0001188_hyperpigmentation | 0.89185005 |
| 79 | MP0001666_abnormal_nutrient_absorption | 0.88054101 |
| 80 | MP0008874_decreased_physiological_sensi | 0.88042110 |
| 81 | MP0001986_abnormal_taste_sensitivity | 0.87230503 |
| 82 | MP0004215_abnormal_myocardial_fiber | 0.87111952 |
| 83 | MP0004484_altered_response_of | 0.85759238 |
| 84 | MP0010368_abnormal_lymphatic_system | 0.84246174 |
| 85 | MP0003690_abnormal_glial_cell | 0.84107365 |
| 86 | MP0002752_abnormal_somatic_nervous | 0.83891427 |
| 87 | MP0001177_atelectasis | 0.82829544 |
| 88 | MP0004147_increased_porphyrin_level | 0.82296711 |
| 89 | MP0005409_darkened_coat_color | 0.81991645 |
| 90 | MP0000013_abnormal_adipose_tissue | 0.78775678 |
| 91 | MP0003632_abnormal_nervous_system | 0.78489636 |
| 92 | MP0004130_abnormal_muscle_cell | 0.77103039 |
| 93 | MP0001963_abnormal_hearing_physiology | 0.76964591 |
| 94 | MP0002837_dystrophic_cardiac_calcinosis | 0.76706168 |
| 95 | MP0003634_abnormal_glial_cell | 0.76333881 |
| 96 | MP0004742_abnormal_vestibular_system | 0.74821400 |
| 97 | MP0004233_abnormal_muscle_weight | 0.74672108 |
| 98 | MP0010329_abnormal_lipoprotein_level | 0.74176858 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.74061367 |
| 100 | MP0000631_abnormal_neuroendocrine_gland | 0.73209494 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.72199071 |
| 102 | MP0005394_taste/olfaction_phenotype | 0.71998234 |
| 103 | MP0005499_abnormal_olfactory_system | 0.71998234 |
| 104 | MP0010234_abnormal_vibrissa_follicle | 0.68373204 |
| 105 | MP0001664_abnormal_digestion | 0.68330668 |
| 106 | MP0003283_abnormal_digestive_organ | 0.68119509 |
| 107 | MP0000604_amyloidosis | 0.60426260 |
| 108 | MP0000920_abnormal_myelination | 0.60344019 |
| 109 | MP0003646_muscle_fatigue | 0.60314236 |
| 110 | MP0004510_myositis | 0.60302875 |
| 111 | MP0003195_calcinosis | 0.58063559 |
| 112 | MP0003137_abnormal_impulse_conducting | 0.57136224 |
| 113 | MP0005195_abnormal_posterior_eye | 0.57021938 |
| 114 | MP0002234_abnormal_pharynx_morphology | 0.55059755 |
| 115 | MP0005248_abnormal_Harderian_gland | 0.54573819 |
| 116 | MP0001943_abnormal_respiration | 0.54145139 |
| 117 | MP0003183_abnormal_peptide_metabolism | 0.53668427 |
| 118 | MP0001485_abnormal_pinna_reflex | 0.52661340 |
| 119 | MP0005670_abnormal_white_adipose | 0.52064813 |
| 120 | MP0010769_abnormal_survival | 0.51385169 |
| 121 | MP0008877_abnormal_DNA_methylation | 0.51270123 |
| 122 | MP0005171_absent_coat_pigmentation | 0.50696187 |
| 123 | MP0003252_abnormal_bile_duct | 0.50242608 |
| 124 | MP0002876_abnormal_thyroid_physiology | 0.49856820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.66885759 |
| 2 | Myokymia (HP:0002411) | 6.56123079 |
| 3 | Focal seizures (HP:0007359) | 5.67378018 |
| 4 | Visual hallucinations (HP:0002367) | 5.23378881 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.90742655 |
| 6 | Febrile seizures (HP:0002373) | 4.59631033 |
| 7 | Atonic seizures (HP:0010819) | 4.43015275 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.35743270 |
| 9 | Absence seizures (HP:0002121) | 4.30483915 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 4.04500483 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.00482449 |
| 12 | Action tremor (HP:0002345) | 3.92916033 |
| 13 | Dialeptic seizures (HP:0011146) | 3.82439263 |
| 14 | Obstructive sleep apnea (HP:0002870) | 3.34758231 |
| 15 | Broad-based gait (HP:0002136) | 3.34056621 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.33374717 |
| 17 | Ankle clonus (HP:0011448) | 3.31758783 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.31433068 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.31124813 |
| 20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.28689167 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.27264845 |
| 22 | Deep venous thrombosis (HP:0002625) | 3.23512997 |
| 23 | Depression (HP:0000716) | 3.22223108 |
| 24 | Mutism (HP:0002300) | 3.21103745 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.17893449 |
| 26 | Poor eye contact (HP:0000817) | 3.13766506 |
| 27 | Postural instability (HP:0002172) | 3.09317048 |
| 28 | Amblyopia (HP:0000646) | 3.07578468 |
| 29 | Genetic anticipation (HP:0003743) | 3.06468095 |
| 30 | Dysmetria (HP:0001310) | 3.03907482 |
| 31 | Abnormal eating behavior (HP:0100738) | 3.03825100 |
| 32 | Anxiety (HP:0000739) | 3.03349945 |
| 33 | Papilledema (HP:0001085) | 3.00939259 |
| 34 | Truncal ataxia (HP:0002078) | 2.99436473 |
| 35 | Ventricular fibrillation (HP:0001663) | 2.91996270 |
| 36 | Central scotoma (HP:0000603) | 2.90793755 |
| 37 | Complement deficiency (HP:0004431) | 2.90507437 |
| 38 | Impaired social interactions (HP:0000735) | 2.83959508 |
| 39 | Abnormal social behavior (HP:0012433) | 2.83959508 |
| 40 | Hyperventilation (HP:0002883) | 2.81259314 |
| 41 | Hemiparesis (HP:0001269) | 2.76458878 |
| 42 | Scanning speech (HP:0002168) | 2.65729673 |
| 43 | Urinary urgency (HP:0000012) | 2.63787947 |
| 44 | Abnormality of macular pigmentation (HP:0008002) | 2.61449045 |
| 45 | Impaired smooth pursuit (HP:0007772) | 2.61105200 |
| 46 | Hemiplegia (HP:0002301) | 2.60521958 |
| 47 | Abnormality of the lower motor neuron (HP:0002366) | 2.58314221 |
| 48 | Excessive salivation (HP:0003781) | 2.57154685 |
| 49 | Drooling (HP:0002307) | 2.57154685 |
| 50 | Tetraplegia (HP:0002445) | 2.56892751 |
| 51 | Peripheral hypomyelination (HP:0007182) | 2.56213022 |
| 52 | Congenital stationary night blindness (HP:0007642) | 2.48998687 |
| 53 | Dysmetric saccades (HP:0000641) | 2.48279185 |
| 54 | Torticollis (HP:0000473) | 2.47710563 |
| 55 | Intention tremor (HP:0002080) | 2.43549577 |
| 56 | Spastic gait (HP:0002064) | 2.43273934 |
| 57 | Epileptiform EEG discharges (HP:0011182) | 2.36427529 |
| 58 | Stereotypic behavior (HP:0000733) | 2.35937860 |
| 59 | Status epilepticus (HP:0002133) | 2.35763401 |
| 60 | Sleep apnea (HP:0010535) | 2.35174622 |
| 61 | Akinesia (HP:0002304) | 2.32543983 |
| 62 | Bradykinesia (HP:0002067) | 2.31466722 |
| 63 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.31008361 |
| 64 | EEG with generalized epileptiform discharges (HP:0011198) | 2.29164995 |
| 65 | Insidious onset (HP:0003587) | 2.27169407 |
| 66 | Termporal pattern (HP:0011008) | 2.27169407 |
| 67 | Progressive inability to walk (HP:0002505) | 2.25522819 |
| 68 | Focal dystonia (HP:0004373) | 2.24842564 |
| 69 | Impaired vibratory sensation (HP:0002495) | 2.24633513 |
| 70 | Neurofibrillary tangles (HP:0002185) | 2.21811296 |
| 71 | Megalencephaly (HP:0001355) | 2.20617236 |
| 72 | Apathy (HP:0000741) | 2.19604999 |
| 73 | Abnormality of binocular vision (HP:0011514) | 2.18544206 |
| 74 | Diplopia (HP:0000651) | 2.18544206 |
| 75 | Scotoma (HP:0000575) | 2.16907236 |
| 76 | Cerebral inclusion bodies (HP:0100314) | 2.16654678 |
| 77 | Fetal akinesia sequence (HP:0001989) | 2.16526035 |
| 78 | Absent speech (HP:0001344) | 2.16513083 |
| 79 | Generalized myoclonic seizures (HP:0002123) | 2.14160179 |
| 80 | Lower limb muscle weakness (HP:0007340) | 2.13978743 |
| 81 | Prolonged partial thromboplastin time (HP:0003645) | 2.12592056 |
| 82 | Cerebral hypomyelination (HP:0006808) | 2.12131236 |
| 83 | Hypsarrhythmia (HP:0002521) | 2.10850028 |
| 84 | Intrahepatic cholestasis (HP:0001406) | 2.10803965 |
| 85 | Hyperthyroidism (HP:0000836) | 2.04292226 |
| 86 | Agitation (HP:0000713) | 2.04248686 |
| 87 | Bundle branch block (HP:0011710) | 2.03305120 |
| 88 | Abnormal EKG (HP:0003115) | 2.02278920 |
| 89 | Polyphagia (HP:0002591) | 2.01323108 |
| 90 | Limb dystonia (HP:0002451) | 1.99152401 |
| 91 | Increased circulating renin level (HP:0000848) | 1.99091593 |
| 92 | Abnormality of complement system (HP:0005339) | 1.99021108 |
| 93 | Craniofacial dystonia (HP:0012179) | 1.98861560 |
| 94 | Inability to walk (HP:0002540) | 1.97636728 |
| 95 | Prolonged QT interval (HP:0001657) | 1.97180636 |
| 96 | Pheochromocytoma (HP:0002666) | 1.97035244 |
| 97 | Diminished motivation (HP:0000745) | 1.96741914 |
| 98 | Incomplete penetrance (HP:0003829) | 1.96364138 |
| 99 | Abnormality of the corticospinal tract (HP:0002492) | 1.95843859 |
| 100 | Choroideremia (HP:0001139) | 1.95831760 |
| 101 | Spinal canal stenosis (HP:0003416) | 1.95322196 |
| 102 | Hyperlipoproteinemia (HP:0010980) | 1.95272642 |
| 103 | Annular pancreas (HP:0001734) | 1.95240886 |
| 104 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.94801781 |
| 105 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.94801781 |
| 106 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.92604485 |
| 107 | Choreoathetosis (HP:0001266) | 1.92365510 |
| 108 | Gait ataxia (HP:0002066) | 1.91020472 |
| 109 | Blue irides (HP:0000635) | 1.83441043 |
| 110 | Heart block (HP:0012722) | 1.81116568 |
| 111 | Insomnia (HP:0100785) | 1.80957498 |
| 112 | Lower limb asymmetry (HP:0100559) | 1.80456204 |
| 113 | Rigidity (HP:0002063) | 1.79873364 |
| 114 | Gonadotropin excess (HP:0000837) | 1.79566773 |
| 115 | Pointed chin (HP:0000307) | 1.79383541 |
| 116 | Specific learning disability (HP:0001328) | 1.78393591 |
| 117 | Rapidly progressive (HP:0003678) | 1.78347492 |
| 118 | Clonus (HP:0002169) | 1.77079858 |
| 119 | Hypoventilation (HP:0002791) | 1.76930377 |
| 120 | Joint hemorrhage (HP:0005261) | 1.76667291 |
| 121 | Neuronal loss in central nervous system (HP:0002529) | 1.75789115 |
| 122 | Syncope (HP:0001279) | 1.75481056 |
| 123 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.73813145 |
| 124 | Abnormality of salivation (HP:0100755) | 1.73386953 |
| 125 | Delusions (HP:0000746) | 1.72746880 |
| 126 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.71425395 |
| 127 | Psychosis (HP:0000709) | 1.71298941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.51023369 |
| 2 | EPHA4 | 4.15813649 |
| 3 | MAP3K9 | 4.08508810 |
| 4 | MAP3K4 | 3.19994043 |
| 5 | TIE1 | 3.18307736 |
| 6 | PAK6 | 2.68626991 |
| 7 | DAPK2 | 2.67624250 |
| 8 | PRKD3 | 2.52736215 |
| 9 | MAP2K7 | 2.46126483 |
| 10 | MINK1 | 2.44494575 |
| 11 | MARK1 | 2.31261541 |
| 12 | KSR2 | 2.30645040 |
| 13 | NTRK2 | 2.12793451 |
| 14 | MAP2K4 | 2.00216870 |
| 15 | NTRK1 | 1.99865318 |
| 16 | CAMKK1 | 1.92053388 |
| 17 | MAP3K12 | 1.81377031 |
| 18 | STK38 | 1.67771542 |
| 19 | RIPK4 | 1.59224188 |
| 20 | MAP3K13 | 1.57956516 |
| 21 | KSR1 | 1.54371178 |
| 22 | CDK5 | 1.53572833 |
| 23 | DAPK1 | 1.45159552 |
| 24 | GRK5 | 1.39728254 |
| 25 | PLK2 | 1.32232721 |
| 26 | ARAF | 1.27299398 |
| 27 | PNCK | 1.23285506 |
| 28 | CAMKK2 | 1.19892142 |
| 29 | TYRO3 | 1.17560568 |
| 30 | CDK19 | 1.17364745 |
| 31 | STK39 | 1.17317744 |
| 32 | MAPK13 | 1.16583506 |
| 33 | CASK | 1.16506262 |
| 34 | TNIK | 1.15859537 |
| 35 | CAMK1 | 1.14526444 |
| 36 | TAOK1 | 1.12655295 |
| 37 | SIK2 | 1.10269269 |
| 38 | LATS2 | 1.10136632 |
| 39 | FES | 1.08710728 |
| 40 | PRKCG | 1.06866868 |
| 41 | UHMK1 | 1.06233751 |
| 42 | MAP3K2 | 1.06149543 |
| 43 | CAMK1G | 1.04590137 |
| 44 | FGFR2 | 1.03632999 |
| 45 | PRPF4B | 1.00950777 |
| 46 | CAMK2A | 1.00316499 |
| 47 | PAK3 | 1.00127764 |
| 48 | STK11 | 0.97269691 |
| 49 | PRKCH | 0.95983387 |
| 50 | PINK1 | 0.95091989 |
| 51 | AKT3 | 0.94770557 |
| 52 | SGK223 | 0.92446719 |
| 53 | SGK494 | 0.92446719 |
| 54 | RET | 0.88112772 |
| 55 | PHKG1 | 0.87688776 |
| 56 | PHKG2 | 0.87688776 |
| 57 | LMTK2 | 0.85132013 |
| 58 | RIPK1 | 0.84763931 |
| 59 | RAF1 | 0.82836664 |
| 60 | CDK15 | 0.77050397 |
| 61 | CDK18 | 0.76916528 |
| 62 | PTK2B | 0.75993229 |
| 63 | MAP3K6 | 0.75673983 |
| 64 | CDK14 | 0.73747464 |
| 65 | SGK2 | 0.72798679 |
| 66 | MARK2 | 0.72135703 |
| 67 | SGK1 | 0.70854291 |
| 68 | CSNK1G2 | 0.69352475 |
| 69 | PKN1 | 0.69212079 |
| 70 | SGK3 | 0.68277638 |
| 71 | MAP3K7 | 0.67653791 |
| 72 | CAMK2B | 0.66839983 |
| 73 | PDK1 | 0.66267194 |
| 74 | OXSR1 | 0.65656646 |
| 75 | CDK11A | 0.65326018 |
| 76 | PRKG2 | 0.65059259 |
| 77 | ALK | 0.64396289 |
| 78 | DYRK1A | 0.64010188 |
| 79 | PDPK1 | 0.63222640 |
| 80 | MAP3K1 | 0.60492024 |
| 81 | BMPR2 | 0.59520213 |
| 82 | NEK1 | 0.56296905 |
| 83 | DDR2 | 0.55864111 |
| 84 | TRIB3 | 0.54711334 |
| 85 | CAMK4 | 0.54087131 |
| 86 | MUSK | 0.54081559 |
| 87 | TNK2 | 0.53837466 |
| 88 | RPS6KA3 | 0.53205103 |
| 89 | PRKCZ | 0.52317791 |
| 90 | EEF2K | 0.51896597 |
| 91 | DMPK | 0.51054340 |
| 92 | FER | 0.50704945 |
| 93 | MAPK10 | 0.49294247 |
| 94 | CAMK1D | 0.48836163 |
| 95 | CDC42BPA | 0.46490102 |
| 96 | PRKG1 | 0.46313231 |
| 97 | PRKCE | 0.46096482 |
| 98 | MAP2K1 | 0.45622481 |
| 99 | CAMK2D | 0.44546415 |
| 100 | CAMK2G | 0.42392279 |
| 101 | WNK1 | 0.41456158 |
| 102 | FRK | 0.41019612 |
| 103 | NME1 | 0.40425470 |
| 104 | NEK6 | 0.39670845 |
| 105 | ROCK2 | 0.39166129 |
| 106 | BRAF | 0.38620803 |
| 107 | WNK3 | 0.38406394 |
| 108 | PRKD2 | 0.37601851 |
| 109 | PRKD1 | 0.36680712 |
| 110 | MAPKAPK5 | 0.36604643 |
| 111 | DAPK3 | 0.36558422 |
| 112 | ROCK1 | 0.35930603 |
| 113 | FYN | 0.35523567 |
| 114 | MAPK12 | 0.35293627 |
| 115 | CCNB1 | 0.35092256 |
| 116 | PRKCA | 0.33302339 |
| 117 | ICK | 0.32507347 |
| 118 | CSNK1D | 0.31406740 |
| 119 | CSNK1A1 | 0.31003124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.46581689 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.21932023 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.74055994 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.67154158 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.56595347 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.56576930 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.46683717 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.41661385 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.40594131 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.39245403 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.29849213 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.21180450 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.19835625 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.12205627 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.07588724 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.91193480 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88748271 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87944015 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.85421574 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 1.81801526 |
| 21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.76305075 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.68084168 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.67862710 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.66392972 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.64309501 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.63656384 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.62260251 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.61911490 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.60490501 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.60038207 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.56205828 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.51790664 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47872617 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42717233 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.42400265 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.33098171 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30697912 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.28285967 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25408473 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23481015 |
| 41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.18639898 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.17847786 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.16638118 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13840539 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13507065 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12774993 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.11526421 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.10466545 |
| 49 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10248666 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09315712 |
| 51 | Glioma_Homo sapiens_hsa05214 | 1.09176333 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09119350 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.06001917 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05861349 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05363694 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00184903 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 0.99066928 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98510602 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98292005 |
| 60 | Axon guidance_Homo sapiens_hsa04360 | 0.96877542 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95190198 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94929837 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91746649 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89894542 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84107143 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83904210 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80144600 |
| 68 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.79752926 |
| 69 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.78655078 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77733746 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77227163 |
| 72 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.76718383 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.76350108 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.75609500 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75568477 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75523264 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74152909 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73889123 |
| 79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73424819 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71679162 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70919413 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68748152 |
| 83 | Bile secretion_Homo sapiens_hsa04976 | 0.66291001 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64616409 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63841907 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63656718 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62441561 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62349562 |
| 89 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62280476 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.61621125 |
| 91 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61009204 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60066738 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59872965 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57052875 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56807562 |
| 96 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55853948 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55480209 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52850335 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52080610 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50903446 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.50690922 |
| 102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48818012 |
| 103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48440185 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48314297 |
| 105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47986146 |
| 106 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47630170 |
| 107 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.47031951 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45330007 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44956168 |
| 110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43288791 |
| 111 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42799844 |
| 112 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.41548703 |
| 113 | Alcoholism_Homo sapiens_hsa05034 | 0.40689596 |
| 114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.40480078 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40381776 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40042570 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39320849 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37956471 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37782949 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37146301 |
| 121 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37125146 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36090111 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.33408325 |
| 124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30289991 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30152998 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.27203400 |
| 127 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27184973 |
| 128 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.26170832 |
| 129 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.25675724 |
| 130 | Tight junction_Homo sapiens_hsa04530 | 0.24947000 |

